Replies to post #182402 on Biotech Values

[DewDiligence]

…the list of potential bidders for ACHN includes the following:
Roche BMY ABBV JNJ NVS and many others…

You can take JNJ and NVS off your list. JNJ now has a nuke by way of Alios and NVS has exited the HCV arena altogether.

By the way, you didn’t comment on the large selling of ACHN by former 10% shareholder, RA Capital (#msg-106809309).